Franklin Genomic Advancements ETF (HELX) Chart & Stock Price History $28.55 -1.41 (-4.71%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatings Franklin Genomic Advancements ETF Stock Price Performance 5 Day Performance-7.30%1 Month Performance-11.20%3 Month Performance-13.36%6 Month Performance-10.18%Year-To-Date Performance-6.30%1 Year Performance+4.66% Receive HELX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address There is a little known company that is changing warfare (Ad)With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t HELX Stock Chart for Sunday, November, 17, 2024 HELX Chart by TradingView Franklin Genomic Advancements ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$30.42$28.62-5.92%$28.95$28.623,069 shs$8.59 million11/14/2024$31.07$30.42-2.09%$30.66$30.412,250 shs$9.13 million11/13/2024$30.80$31.07+0.88%$31.09$31.07733 shs$9.32 million11/12/2024$31.45$30.80-2.07%$31.23$30.80210 shs$9.24 million11/11/2024$31.53$31.45-0.25%$31.84$31.456,083 shs$9.44 million11/08/2024$31.28$31.49+0.66%$31.49$31.434,382 shs$9.45 million Get the Latest News and Ratings for HELX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$30.96$31.28+1.04%$31.31$31.164,071 shs$9.39 million11/06/2024$30.79$30.96+0.56%$31.17$30.962,885 shs$9.29 million11/05/2024$30.51$30.79+0.92%$30.79$30.611,478 shs$9.24 million11/04/2024$30.51$30.51$30.56$30.455,697 shs$9.15 million11/01/2024$30.30$30.51+0.69%$30.56$30.455,697 shs$9.15 million10/31/2024$30.79$30.30-1.59%$30.31$30.229,658 shs$9.09 million10/30/2024$31.01$30.79-0.71%$30.84$30.763,759 shs$9.24 million10/29/2024$30.97$31.01+0.12%$31.01$30.991,927 shs$9.30 million10/28/2024$30.72$30.97+0.84%$31.13$30.882,243 shs$9.29 million10/25/2024$31.12$30.72-1.30%$30.95$30.72504 shs$9.22 million10/24/2024$31.03$31.12+0.29%$31.17$30.833,094 shs$9.34 million10/23/2024$31.37$31.03-1.08%$31.31$31.032,507 shs$9.31 million10/22/2024$31.93$31.37-1.76%$31.45$31.342,163 shs$9.41 million10/21/2024$32.37$31.93-1.34%$32.29$31.866,404 shs$9.58 million10/18/2024$32.15$32.37+0.67%$32.39$32.223,005 shs$9.71 million10/17/2024$32.23$32.15-0.25%$32.38$32.15701 shs$9.65 million10/16/2024$32.23$32.23$32.24$32.082,272 shs$9.67 million Related Companies MOTO Stock Price Chart SPCX Stock Price Chart COPJ Stock Price Chart ESUS Stock Price Chart GCLN Stock Price Chart RBLD Stock Price Chart AQWA Stock Price Chart NIKL Stock Price Chart SIMS Stock Price Chart IVRA Stock Price Chart Receive HELX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. This page (BATS:HELX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
